Übersetzung für "Compound patent" in Deutsch

A compound according to patent claim 1, in which Ph represents phenyl that is unsubstituted or substituted by lower alkyl, lower alkoxy, lower alkylthio, lower alkanoyloxy, halogen, trifluoromethyl, carboxy, lower alkoxycarbonyl, cyano and/or nitro, and R represents carboxy, carboxy esterified by a lower aliphatic alcohol, or carbamoyl having as amino group amino that is unsubstituted or mono- or di-substituted by lower aliphatic radicals, or a salt thereof with a base.

There has been no lack of attempts to remedy these shortcomings by crosslinking the polyether resins by adding a crosslinking agent such as a specific biphenylene compound (q.v. U.S. Pat. No. 4,269,953) or sulfur or an organic sulfur compound (Britist patent specification No. 1 357 114), or by end capping polyether polymers with reactive end groups that effect crosslinking.

The surface conditioner can also contain, besides the abovementioned colloidal titanium compounds and alkaline phosphates, such additives as perborate, carbonate, orthophosphate and watersoluble anionic organic compound (Japanese Patent Appln.

There has been no lack of attempts to remedy these shortcomings by crosslinking the polyether resins by adding a crosslinking agent such as a specific biphenylene compound (q.v. U.S. Pat. No. 4,269,953) or sulfur or an organic sulfur compound (British patent specification No. 1 357 114), or by end capping polyether polymers with reactive end groups that effect crosslinking.

In July 2018, the court ordered that Bayer's compound patent protection for XareltoTM until 2024 is valid and that the patent is infringed.

It was originally developed by Pfizer which described the compound in a patent in 2009, but was later abandoned and never tested on humans.

In July 2018, the court ordered that Bayer's compound patent protection for Xarelto™ until 2024 is valid and that the patent is infringed.

The invention relates to a process for the preparation of cyclic ureas of the structure type of benzimidazolones I (see patent claim 1) in which R1 and R2, independently of one another, are hydrogen, alkyl having 1 to 6 carbon atoms or alkoxy having 1 to 3 carbon atoms by reaction of the corresponding diamino compound II (see patent claim 1) with carbon dioxide, if appropriate in the presence of catalysts, which comprises carrying out the reaction in the presence of water as reaction medium under superatmospheric pressure at a temperature of at least 120° C. The use of water turns out to be extremely advantageous, because the process, due to the permanent presence of the liquid medium water, remains technically feasible even on a large scale.

The compounds of the patent specification mentioned also proved especially effective in the rat-ear test according to Tonnelli.

We have now found, surprisingly, that the novel active substances according to the present invention are superior to the commercially available products and to the structurally most closely related compounds in the patent literature in respect of selectively controlling weeds.

Surprisingly, it has now been found that the novel compounds of this invention are superior in selective weed control to the products introduced onto the market and to the structurally most closely related compounds of the patent literature and, in addition, have plant growth regulating properties.

New odorants can however be patented, and so the company that invented the material can decide not to sell a patented odorant but to keep it as a captive for their own perfumes only, thereby extending the patent protection for that compound on the perfume formulation, since the patented compound can only be produced by the patent owner.

Surprisingly, it has now been found that the novel compounds of this invention are superior in selective weed control to the products introduced onto the market and to the structurally most closely related compounds of the patent literature.

Mengel gives the example of OM AB, a Swedish company formed to exploit a patented compound for magnetic resonance imaging.

Diagnostic tests, potential drug targets and families ofpotential antiviral compounds are methodically patented, even if thismeans postponing the publication of results in scientific journals.

The compounds claimed in patent application Le A 26 864 filed at the same time as the present application also have a marked viscosity-stabilizing effect on the elastanes containing carbonate-linked block diol.

Basic polyamides of this type are also described, for example, as starting compounds for the reaction with polyfunctional compounds in German patent specification Nos. 1,177,824 and 1,771,814.

In addition to the 4,4'-isomers of the binuclear compounds, this patent also discloses 3,3'-diamino-diphenyl sulfone and 3,4'-diamino-biphenyl.